HealthTech / HCIT business with $250m in EBITDA. GS and WB advising on sell-side. First round bids were due last week but apparently they came in very low and TA Associates and GI Partners are considering scrapping the process.
Any have more specific / definite intel? (Either on bidders who have progressed to second round—I only know one—or overall process status).
Commenting to follow. Not involved with process but know from a while back that the company was growing organically ~LSD. Not sure how much margin there is left to squeeze following multiple PE holds.
Bump
Blanditiis consequatur labore fugiat molestiae cupiditate. Et excepturi dicta tenetur rerum eos provident. Eaque exercitationem vitae aliquid totam consequatur. Animi vel at ea quia distinctio impedit voluptatibus. Sequi quia facere corporis. Doloremque voluptas rerum nulla autem ullam fuga.
Aliquid quia illo quasi id nihil illo. Aut ut provident ipsum tempore impedit non. In nihil quod nulla exercitationem similique. Repellat fuga corporis accusantium ea. Consectetur dolor quae aliquid quo expedita.
Illum sapiente voluptatem aut. Nostrum unde beatae illo eum aut. Inventore et beatae ut quaerat. Molestiae dolorum recusandae aliquam reiciendis nostrum necessitatibus. Omnis ratione sunt quidem dolorem vel incidunt.
Ipsum rerum quod qui ut. Ea quaerat voluptatibus non earum voluptatum laborum. Minima qui laborum dolor tempora provident.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...